Drug profile · INN
glycopyrronium bromide
ENUREV BREEZHALER
glycopyrronium bromide (ENUREV BREEZHALER) is a muscarinic acetylcholine receptor m1 antagonist.
EMA: approved PMDA: approved Respiratory system (R03) R03BB06
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — glycopyrronium bromide
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
glycopyrronium bromide (ENUREV BREEZHALER) is a muscarinic acetylcholine receptor m1 antagonist.
Key facts
INN glycopyrronium bromide
Brand ENUREV BREEZHALER
Mechanism Muscarinic acetylcholine receptor M1 antagonist
Target Muscarinic acetylcholine receptor M1
Therapeutic class Respiratory system (R03)
ATC code R03BB06
Mechanism of action
Muscarinic acetylcholine receptor M1 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is glycopyrronium bromide?
glycopyrronium bromide (ENUREV BREEZHALER) is a muscarinic acetylcholine receptor m1 antagonist.
What is the brand name for glycopyrronium bromide?
ENUREV BREEZHALER is a marketed brand name for glycopyrronium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.